Lisa Y Law

5PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2025
Real-World Treatment Patterns and Outcomes of Zanubrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL).

Margaret Li Krackeler, Bryant H Chee, Arthur K Orchanian

|Jun 27, 2024
Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study.

Helen W Wong, Vivian H Nguyen, Timothy Y Mok

|Mar 18, 2024
Vaccination of Adults With Cancer: ASCO Guideline.

Mini Kamboj, Kari Bohlke, Deana M Baptiste

|Dec 15, 2022
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.

Sarit Assouline, Laura C Michaelis, Megan Othus

|Mar 26, 2021
Atypical manifestations of coronavirus disease 2019 (COVID-19)-associated autoimmune thrombotic thrombocytopenic purpura.

Lisa Law, Gwendolyn Ho, Dazhi Cen

Pageof 1

Frequent Collaborators

1 joint publications

Gwendolyn Ho

1 joint publications

Rita L Hui

1 joint publications

Margaret Li Krackeler

1 joint publications

Anna B Moseley